Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Eli Lilly Stock Slips After Earnings Beat. Forecast Is the Issue.
12:14pm, Tuesday, 01'st Nov 2022
The pharmaceutical group slashed its full-year fiscal guidance for the third quarter in a row. Investors are also looking at updates on the much-hyped drug Mounjaro.
Pfizer beats estimates, Eli Lilly cuts outlook
10:39am, Tuesday, 01'st Nov 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss quarterly earnings for Pfizer and Eli Lilly.
Eli Lilly (LLY) Q3 Earnings and Revenues Beat Estimates
09:02am, Tuesday, 01'st Nov 2022
Lilly (LLY) delivered earnings and revenue surprises of 0.51% and 0.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Lilly's new Type 2 diabetes drug had $187 million in sales in the third quarter
07:30am, Tuesday, 01'st Nov 2022
Eli Lilly & Co. Inc. LLY, +0.61% said its new Type 2 diabetes treatment Mounjaro brought in $187.3 million in sales in the third quarter of the year, beating the FactSet consensus of $183.0 million. I
Eli Lilly Earnings Beat but the Stock Falls as Forecast Is Cut
07:11am, Tuesday, 01'st Nov 2022
Eli Lilly slashed its full-year fiscal guidance for the third quarter in a row. Investors are also looking at updates on the much-hyped drug Mounjaro.
Lilly beats adjusted earnings and revenue target but trims its 2022 view
06:54am, Tuesday, 01'st Nov 2022
Eli Lilly & Co. LLY, +0.61% shares dipped 1.1% in premarket trades on Tuesday after the drug maker trimmed its 2022 earnings outlook, but posted stronger-than-expected third-quarter results. Lilly's n
Dow Notches Strongest Month of Trading Since 1976
07:34pm, Monday, 31'st Oct 2022
At +11%, it's the best October on record for the blue-chip index and the strongest single-month of trading since the U.S. Bicentennial.
Eli Lilly Q3 Preview: Can Shares Stay Hot?
05:18pm, Friday, 28'th Oct 2022
LLY shares have been a bright spot in an otherwise dim market in 2022, outperforming the S&P 500 across several timeframes.
Three buys and a bail: AbbVie, Eli Lilly, Humana and Moderna
02:25pm, Friday, 28'th Oct 2022
Gina Sanchez, Lido Advisors chief market strategist, joins 'The Exchange' to discuss three stocks Sanchez is interested in buying and one the strategist is bailing on.
Eli Lilly Is Now Worth More Than Nvidia, A Correction Seems Highly Likely
12:33pm, Friday, 28'th Oct 2022
Eli Lilly stock has defied the bear market of 2022 and is now up more than 30% year-to-date after a recent breakout. Thanks to hype around several drugs in the company's pipeline, primarily donanemab
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:32am, Tuesday, 25'th Oct 2022
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Stocks This Week: Buy Merck And Eli Lilly
06:00am, Monday, 24'th Oct 2022
This is likely the last bearish week before a rally runs through the next two months.
Chartmaster: Big move in vaccine names
06:13pm, Friday, 21'st Oct 2022
Carter Worth of Worth Charting on what's next in the health care sector. With CNBC's Frank Holland and the Fast Money traders, Tim Seymour, Steve Grasso, Guy Adami and Julie Biel.
4 Biotech Stocks Set to Outpace Q3 Earnings Estimates
10:32am, Friday, 21'st Oct 2022
Let us take a look at some biotech stocks, ARGX, BMRN, LLY and GMAB, which are poised to beat on third-quarter earnings.
Lilly Confirms Date and Conference Call for Third-Quarter 2022 Financial Results Announcement
10:00am, Wednesday, 19'th Oct 2022
INDIANAPOLIS , Oct. 19, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2022 financial results on Tuesday, Nov. 1, 2022. Lilly will also conduct a conference cal
